Cassia absus Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Caesalpiniaceae. |
| Habitat | Throughout India. |
| Ayurvedic | Chakshushyaa, Aranyakulathhikaa, Kataka. |
| Unani | Chaaksu. |
| Siddha / Tamil | Muulaipalyirai, Kaattukollu. |
| Folk | Ban Kulathi. |
| Action | Seed—bitter, blood-purifier, astringent, stimulant, diuretic. Used topically for leucoderma, ringworm, venereal ulcers and other skin diseases. Roots—purgative. |
| Dosage | Seed—3–6 g powder. (CCRAS.) |
| Taxonomic Cohort | Genus Cassia (10 documented species); Family Caesalpiniaceae (25 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Cassia absus (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Caesalpiniaceae (primary family classification: Caesalpiniaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Throughout India.
Across classical and vernacular Indian systems of medicine, Cassia absus is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Chakshushyaa, Aranyakulathhikaa, Kataka; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Chaaksu; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Muulaipalyirai, Kaattukollu; in regional Indian folk and vernacular ethnobotany as Ban Kulathi. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Cassia absus are: Seed—bitter, blood-purifier, astringent, stimulant, diuretic. Used topically for leucoderma, ringworm, venereal ulcers and other skin diseases. Roots—purgative. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Cassia absus establish the following evidence base: Seeds gave sitosterol-beta-D-glucoside and alkaloids—chaksine and isochaksine. Chaksine is found to be antibacterial against Micrococcus pyogenes var. aureus and Streptococcus haemolyticus. It stimulates contraction of different tissues of plain muscles, like uterus, intestine, bladder, and muscles in blood vessels. It depresses the parasympathetic nerveendings of certain organs like intestine and bladder. Chaksine has ganglionblocking property. Chaksine and isochaksine possess a local anaesthetic effect intradermally. It produces a sustained fall in blood pressure of anaesthetized animals and produces a weak anti-acetylcholine effect. Roots also contains anthraquinones and aloeemodin.
In specialized pharmacognostic classifications, Cassia absus is also represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

Figure 1: Authenticated crude herb specimen — Cassia absus seed.

Botanical Reference 1: Chamaecrista absus — Botanical specimen

Botanical Reference 2: Chamaecrista absus — Botanical specimen

Botanical Reference 3: Cassia absus — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Cassia comprises 10 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Cassia alata (Action: Leaf—used in skin diseases like herpes, blotch, eczema, mycosis (washerman’s…); Cassia angustifolia (Action: Purgative (free from astringent action of rhubark type herbs, but causes gripe)…); Cassia auriculata (Action: Roots—used in skin diseases and asthma. Flowers enter into compounds for…); Cassia fistula (Action: Flowers and pods— purgative, febrifugal, astringent, antibilious. Seed…); Cassia obovata (Action: An adulterant of the true senna. Leaves and seeds—purgative and anthelmintic) along with 4 additional congeneric species. Comparing Cassia absus alongside its congeners in genus Cassia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Caesalpiniaceae encompasses 25 documented medicinal species (1.38% of the 1,814-species flora). Other representative medicinal members of Caesalpiniaceae include: Bauhinia acuminata (Kaanchnaara), Bauhinia malabarica (Ashmantaka var), Bauhinia purpurea (Kovidaara), Bauhinia racemosa (Ashmantaka), Caesalpinia bonduc (Puutikaranja). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 2: Quantitative documentation profile across all 25 medicinal species of family Caesalpiniaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Cassia absus are prescribed as follows: Seed—3–6 g powder. (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Cassia absus integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.